
The purpose of the current study was to determine the toxicity and response of a fixed dose zzso fluid zzso zzso in the treatment of patients with newly diagnosed zzso meningitis zzso zzso reportedly occurs in zzso to zzso of patients with known zzso Currently available treatment options are limited and provide only modest zzso 

zzso patients zzso age, 55 zzso with clinically and zzso documented zzso received zzso zzso zzso zzso included lung (8 zzso breast (5 zzso primary brain tumor (4 zzso zzso zzso (4 zzso melanoma (4 zzso colon (1 zzso and prostate (1 zzso zzso zzso zzso (19 of 27 zzso or systemic chemotherapy (17 of 27 zzso was administered based on clinical zzso zzso was administered at a fixed dose zzso zzso every day given 5 days per week every other week for 8 weeks zzso Patients were evaluated by zzso zzso and zzso examination at the conclusion of induction zzso Responding patients continued to receive zzso (5 consecutive days every 4 weeks) with monthly zzso 

Seven of 27 patients zzso treated with zzso had a zzso response and either stable or improved zzso status at the conclusion of zzso Eight patients zzso developed disease progression during induction therapy and did not complete the zzso induction course of zzso At the conclusion of induction therapy, 12 patients zzso had persistently positive zzso zzso although they were clinically zzso In responding patients, time to zzso disease progression ranged from 8 weeks to 40 weeks zzso 20 zzso zzso zzso as transient chemical zzso (5 of 27 zzso zzso of all treatment zzso The zzso zzso disease zzso survival was zzso 

zzso appears to have modest activity against zzso and easily managed zzso 

